59
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Searching for the Magic Bullet Against Cancer: The Butyrate Saga

, , , &
Pages 275-289 | Received 28 Dec 2000, Published online: 01 Jul 2009

References

  • Grignani Dematteis F., Nervi S. C. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 1998; 391: 815
  • Wang J, Saunthararajah X., Redner V. RL, Liu J M. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res 1999; 59: 2766
  • He L, Guidez Z., Tribioli F. C., et al. Distinct interactions of PML-RAR alpha and PLZF-RAR alpha with co-repressors determine differential responses to RA in, APL. Nat Genet 1998; 18: 126
  • Gelmetti Zhang V., Fanelli S. JM., et al. Aberrant recruitment of the nuclear receptor corepressor- histone deacetylase complex by the acute myeloid leukemia fusion partner, ETO. Mol Cell Biol 1998; 18: 7185
  • Lutterbach Westendorf B., Linggi J. J. ETO. a target of t(8;21) in acute leukemia, interacts with N-CoR and mSin3 corepressors. Mol Cell Biol 1998; 18: 7176
  • Freeman H J. Effects of differing purified cellulose, pectin, and hemicellulose fiber diets on fecal enzymes in 1,2-dimethylhydramine-induced rat colon carcinogenesis. Cancer Res 1986; 46(11)5529–32
  • Widmer Fassihi J., Kschlichter S., Swheeler C., Crute S. K, King E. B, Nutile N., McMenemyNoll N., Daniel W. W, Ha S., Kim J. KH, Witters L A. Identification of a second human acetyl-CoA carboxylase gene. Biochem J 1996; 316(Pt 3): 915–22
  • Ruppin Bar H., MeirsSoergel S., Wood H. KCM, Schmttt M G. Jr: Absorbtion of short-chain fatty acids by the colon. Gastroenterlogy 1980; 78(6)1500–7
  • Binder H J. The pathophysiology of diarrhea. Hosp Pract 1984; 1984(10)107–13
  • Harig J, Ng M., Dudeja K. E, Brasitus K. P, Ranaswamy A. TK. Transport of n-butyrate into human colonic luminal membrane vesicles. Ann J Physiol Sep; 1996; 271: G415–22
  • Stein Schroder J., Milovic O. V, Caspary W F. Mercaptopropionate inhibits butyrate uptake in isolated apical membrane vesicles of the distal colon. Gastroenterology 1995 1995; 108(3)673–9
  • Sehested Diernaes J., Moller L., Skadhauge D. P. Transport of butyrate across the isolated bovine rumen epithelium-interaction with sodium chloride and bicarbonate. Comp Biochem Physiol A Mol Integr Physiol 1999; 4: 399–408
  • Butzner J, Parmar D., Bell R., Dalal J. CV. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 1996; 38(4)568–73
  • Der Hond, Hielf E., Evenepoel M., Peeters P., Ghoos M. Y, Rutgeerts P R. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenetrology 1998; 115(3)584–90
  • Velazquez O, Seto C., Chouzhou W. R, Breen D., Fisher F. JD, Rombeau J L. Butyrate inhibits deoxycholate-induced increase in colonic mucosal DNA and protein synthesis in vivo. Dis Colon Rectum 1997; 40(11)1368–75
  • Novogrodsky Dvir A., Ravid A., Shkolnik A., Stenzel T., Rubin H. K, Zaizov L. AR. Effect of polar organic compounds on leukemic cells: Butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer 1983; 151(1)9–14
  • Daniel Brazier P., Cerutti M., Pieri I., Tardivel F., Desmet I., Baillet G., Chany J.C. Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts. Clin Chim Acta 1989; 181(3)255–63
  • Brazier Desmet M., Pieri G., Daniel F. P. A rapid, simple and sensitive gas chromatographic micromethod for the quantitation of butyric acid and other short-chain fatty acids in serum. Clin Chim Acta. 1985; 14148(3)261–5
  • Pouillart Cerutti P., Ronco I., Villa G., Chany P. C. Enhancement by stable butyrate derivatives of antitumor and antiviral actions of interferon. Int J Cancer 1992; 1951(4)596–601
  • Miller A, Kurschel A., Osieka E. R, Schmidt C G. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer and Clin Oncology, 23: 1283–1287
  • Perrine S P, Faller D V. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies. Experienta 1993; 49(2)133–7
  • Pouillart Cerutti P., Ronco I., Villa G., Chany P. C. Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy. Int J Cancer 1991; 49(1)89–95
  • Planchon Raux P., Magnien H., Ronco V., Villa G., Crepin P., Brouty M., Boye D. New stable butyrate derivatives alter proliferation and differentiation in human mammalian cells. Int J Cancer 1991; 48(3)443–9
  • Planchon Magnien P., Beaupain V., Mainguene R., Ronco C., Villa G., Brouty P., Boye D. Differential effects of butyrate derivatives on human breast cancer cells grown as organic nodules in vitro and as xenografts in vivo. In vivo 1992; 6(6)605–10
  • Calabresse Venturini C., Ronco L., Villa G., Chomienne P., Belpomme C. D. Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line. Biochem Biophys Res Common 1993; 195(1)31–8
  • Calabresse Venturini C., Ronco L., Villa G., Degos P., Belpomme L., Chomienne D. C. Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone gucose-butyrate. Biochem Biophys Res Commun 1994; 201(1)266–83
  • Planchon Pouillart P., Ronco P., Villa G., Pieri P. F. Differential elimination of synthetic butyric triglycerides in vivo: a pharmacokinetic status. J Pharm Sci 1993; 10: 1046–8
  • Pouillart Ronco P., Cerutti G., Chany I., Villa C. P. Low level toxicity and antitumor activity of butyric mono and polyester monosaccharide derivates in mice. J Biol Regul Homeost Agents 1990; 4(4)135–41
  • Pouillart Douillet P., Scappini O., Gozzini B., Santini A., Grossi V., Pagliai A., Strippoli G., Rigacci P., Ronco L., Villa G. P. Regioselective synthesis and biological profiling of butyric and phenylalkylcarboxylic esters derivated from D-mannose and xylitol: influence of alkyl chain lenght on acute toxicity. Eur J Pharmac Sci 1998; 7: 93–106
  • Perrine S, Dover P., Daftari H. G, Walsh P., Jin T. C, Mays Y. A, Fauler D V. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globine gene expression in vitro and in vivo. Br J Haematol 1994; 88(3)555–61
  • Egorin M, Yuan J., Sentz M. Z, Plaisance L. DK, Eiseman J L. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate in mice and rats. Cancer Chemother Pharmacol 1999; 43(6)445–53
  • Lyman G, Papahadjopoulos H. D, Preisler H D. Phospholipid membrane stabilization by dimethylsulfoxide and other inducers of Frien leukemic cell differentiation. Biochim Biophys Acta 1976; 19448(3)460–73
  • Takahashi Yamada E., Saito M., Kuboyama M., Ogasa M. K. Differentiation of cultured Friend leukemia cells induced by short-chain fatty acids. Gann 1975; 66: 577–580
  • Leibovitch M, Leibovitch P., Harel A. S, Kruh J. J. Effect of sodium butyrate on messenger RNA populations in myogenic cells in culture. Differentiation 1982; 22(2)106–12
  • Raymond K, Raymond C. GJ, Johnson J D. In vivo modulation of yeast tRNA gene expression by 5′ flanking sequences. Embo j 1985; 10: 2649–56
  • Sterner Vidali R. G, Allfrey V G. Studies of acetylation in HMG-1. J Biol Chem 1979; 254(22)11577–83
  • Levy-Wilson B. Enhanced phosphorylation of high-mobility-group proteins in nuclease-sensitive mononucleosomes from butyrate-treated HeLa cells. Proc Natl Acad Sci USA 1981; 78(4)2189–93
  • Riggs M, Whittaker G., Neumann G. RJR., Ingram V M. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 1977; 268(5619)462–4
  • Sealy Chalkley L. R. The effect of sodium butyrate on histone modification. Cell 1978; 14: 115–121
  • Boffa L, Vidali C., Mann G. RS, Allfrey V G. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem 1978; 253(10)3364–6
  • Candido E, Reeves P. R, Davie J R. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 1978; 14(1)105–13
  • Kruh Defer J., Tichonicky N. L. Molecular and cellular action of butyrate. C R Seances Soc Biol Fil 1992; 186(1-2): 12–25
  • Boffa L, Gruss C. RJ, Allfrey V G. Manifold effects of sodium butyrate on nuclear function. Selective and reversible inhibition of phosphorylation of histones H1 and H2A and impaired methylation of lysine and arginine residues in nuclear protein fractions. J Biol Chem 1981; 256(18)9612–21
  • Gill R, Christakos K. S. Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3 and butyrate-inducible responses. Proc Natl Acad Sci USA 1993; 90: 2984–2988
  • Lee D, Hayes Y., Pruss J. JD., Wolffe A P. A positive role for histone acetylation in transcription factor access to nucleosomal, DNA. Cell 1993; 72(1)73–84
  • Davie J R. Histone modifications, chromatine structure and the nuclear matrix. J Cell Biochem 1996; 62(2)149–57
  • Davie J R. Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin. Mol Biol Rep 1997; 3: 197–207
  • Zhang Y, Iratni R., Erdjument H., BromageTempst P., Reinberg P. D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 1997; 89: 357–364
  • Ip Y, Jackson T., Meier V., Chalkley J. R. The separation of transcriptionally engaged genes. J Biol Chem 1988; 263(28)14044–14052
  • Hendzel M, Delcuve J. GP, Davie J R. Histone deacetylase is a component of the internal nuclear matrix. J Biol Chem 1991; 266(32)21936–42
  • Walia Chen H., Sun Y. H, Holth M. JLT., Davie J R. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing, DNA. J Biol Chem 1998; 14516–14522
  • Newmark H, Lupton L. JR, Young C W. Butyrate as differentiating agent: pharmacokinetics analogues and current status. Cancer Lett 1994; 78(1-3): 1–5
  • Schlake Klehr T., WirthYoshida D., Beppu M., Bode T. J. Gene expression within a chromatin domain: the role of core histone hyperacetylation. Biochemistry 1994; 33: 4197–4206
  • Lester E, Lemkin P. PF, Lipkin L E. Protein indexing in leukemias and lymphomas. Ann NY Acad Scie 1984; 428: 158–72
  • Lea A, Verrel M. MR, Hodge S K. Induction of histone acetylation and growth regulation in erythroleukemia cells by 4-phenylbutyrate and structural analogs. Anticancer Res 1999; 19: 1971–1976
  • Cuisset Tichonicky L., Delpech L. M. A protein phosphatase is involved in the inhibition of histone deacetylation by sodium butyrate. Biochem Biophys Res Comm 1998; 246: 760–764
  • Garcia-Bermejo Vilaboa L., Perez E. N, Galan C., Aller E. P. Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis. Exp Cell Res 1997; 236: 268–274
  • Mivechi N, Ouyang F., Monson H. JM, Hahn G M. Correlation of heat resistance and HSP70A mRNA levels in human tumor cells measures competitive quantitative polymerase chain reaction. Int J Radiat Oncol Biol Phys 1994; 30(1)141–9
  • Twomey B, Amin M., Isenberg V. DA, Latchman D S. Elevated levels of the 70 kD heat shock protein in patients with systemic lupus erythematosus are not dependent on enhanced transcription of the hsp70 gene. Lupus 1993; 5: 297–301
  • Fincato Polentaruttin G., Mantovani A., Colotta A. F. Expression of heat-inducible gene of the HSP70 family in human myelomonocytic cells regulation by bacterial products and cytokines. Blood 1991; 77(3)576–586
  • Filippovich Sorokina I., Khanna N. KK, Lavin M F. Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of mRNA. Biochem Biophys Res Commun 1994; 198(1)257–65
  • Burns L, Glauber J. JG, Ginder G D. Butyrate induces selective transcriptional activation of a hypomethylated embryionic globin gene in adult erythroid cells. Blood 1988; 72(5)1536–42
  • Giardina P J, Hilgerther M W. Update on thalassemia. Pediatr Rev 1992; 2: 55–62
  • Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem 1982; 42(2)65–82
  • Vidali Boffa G., Bradbury C. LEM., Allfrey V G. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated of histones H3 and H4 and increased Dnase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA 1978; 75(5)2239–43
  • Boffa L, Lupton C., Mariani R. J, Ceppi R. M, Newmark M., Scalmati L. H, Lipkin A. M. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 1992; 52(21)5906–12
  • Kyristis Tsokos A., Chader M. G. Attachment culture of human retinoblastoma cells: long-term culture conditions and effects of dibutyril cyclic, AMP. Exp Eye Res 1984; 38(4)411–21
  • Samid Yeh D., Prasanna A. P. Induction of erythroid differentiation and fetal hemopglobin production in human leukemic cells treated with phenylacetate. Blood 1992; 80(6)1576–81
  • Wakselman Cerutti M., Chany I. C. Anti-tumor protection induced in mice by fatty acid conjugated: alkyl butyrates and poli (ethylene glycol) dibutyrates. Int J Cancer 1990; 46(3)462–7
  • Vavasseur Berrada F., Heuze A., Jotereau F., Meflah F. K. Fucose and galactose receptor and liver recognition by lymphoma cells. Int J Cancer 1990; 45(4)744–51
  • Samid Ram D., Hudgins Z., Shacks R. W, Walbridge L., Oldfield S. EH, Ryers C E. Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res 1994; 54(4)891–5
  • Wade P, Pruss A. D, Wolffe A P. Histone acetylation:chromatin in action. Trends Biochem Sci 1997; 22: 128–32
  • Rephaeli Rabizadeh A., Aviram E., Shaklai A., Ruse M., Nudelman M. A. Derivatives of butyric acid as potential anti-neoplastic agents. Int J Cancer 1991; 49: 66–72
  • Fibach Prasanna E., Rodgers P., Samid P. GD. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia. Blood 1993; 82(7)2203–9
  • Ginsburg Salmon C., CeronVassilieg D., Robian D., Rotschild C., Fontenay C., RoupiaStieltjes M., Sicard N. D. Unusual occurrence of spontaneous haematomas in three asymptomatic, HIV. Infected haemophilia patients a few days after the onset of ritonavir treatment. AIDS 1997; 3: 388–9
  • Prasad C, Hariharan N., Salva B. Congenital short small intestine. Indian Pediatr 1990; 27(8)869–71
  • Samid Shack D. S, Myers C E. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by non pharmacological concentrations of phenylacetate. J Clin Invest 1993; 91(5)2288–95
  • Prasad K N. Butyric acid: Small Fatty CID WITH DIVERSE BIOLOGICAL FUNCTIONS. Life Sci 1980; 27: 1351–1358
  • Chany Cerutti C., Mace I. B. Effect of coordinated therapeutic assays using, C. parvum, interferon and arginine butyrate in spontaneous disease and survival of AKR mice. Int J Cancer 1983; 32(3)379–83
  • Poikier Lokiec O., Najean F. Y. Enhancement by sodium butyrate of the cytotoxic effect of methotrexate on leukemic cells. CR Seances Acad Sci III 1982; 294(23)1101–1104
  • Ebert P, Salcman S. M. Differentiation therapy is potentiated by chemotherapy and hyperthermia in human and canine brain tumor cells in vitro. Neurosurgery 1994; 34(4)657–64
  • He R Y, Breitman T R. Retinoic acid inhibits sodium butyrate-induced monocytic differentiation of HL60 cells synergistically inducing granulocytoid differentiation. Eur J Haematol 1991; 46(2)93–100
  • Leder Leder A. P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 1975; 5(3)319–22
  • Schneider F H. Effects of sodium butyrate on mouse neuroblastoma cells in culture. Biochem Pharmacol 1976; 25: 2309–2317
  • Multhaup Csordas I., Grunicke A., Pfister H., Puschendorf R. B. Conservation of the acetylation pattern of histones and the transcriptional activity in ascites tumor cells by sodium butyrate. Arch Biochem Biophys 1983; 222(2)497–503
  • Nozawa Engvall S., Kano E., Kurihara S. S, Fishman W H. Sodium butyrate produces concordant expression of “early placental” alkaline phosphatase pregnancy-specific beta 1-glycoprotein and human chronic gonadotropin beta-subunit in newly established uterine cervical cancer cell line (SKG-IIIa). Int J Cancer 1983; 32(3)267–72
  • Kyritsis Joseph A. G, Chader G J. Effects of butyrate, retinol, and retinoic acid on human Y-79 retinoblastoma cells grown on monolayer cultures. J Natl Cancer Inst 1984; 73(3)649–54
  • McIntyre L J, Kim Y S. Effects of sodium butyrate and dimethylsulfoxide on human pancreatic tumor cell lines. Eur J Cancer Oncol 1984; 20(2)265–71
  • Kim S, He H. SQ, Kim J H. Modification of thermosensitivity of HeLa cells by sodium butyrate, dibutyril cyclic adenosine 3′:5′-monophosphate, and retinoic acid. Cancer Res 1984; 44(2)697–702
  • de Haan J, Gevers B. W, Parker M I. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and in transformed counterparts. J Mol Biol 1984; 173(3)361–88
  • Langdon S, Hawkes P., Hay M. M, Lawrie G. F, Schol S. S, Hilgers J. D, Leonard J. RC, Smyth I F. Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res 1988; 48(21)6161–5
  • Litvak D, Hwang A., Evers O. K, Townsend M. BCM, Jr. Induction of apoptosis in human gastric cancer by sodium butyrate. Anticancer Res 2000; 20(2A): 779–84
  • Gupta Alpini S., Vermeru P. R, Hurston E. E, Shafrttz D A. Butyrate snchronization of hepatocytes: modulation of cycling and cell cycle regulate expression. Growth Factors 1994; 10(3)171–180
  • Olsen J, Sechelsky C. Use of sodium butyrate to enhance production of retroviral vectors expressing CFTR cells. Hum Gene Ther 6 1995; 6(9)1195–1202
  • Kvale Brandtzaeg D. Constitutive and cytokine induced expression of HLA molecules, secretory component intercellular adhesion molecule-1 is modulated by butyrate in colonic epithelial cell HT-29. Gut 1995; 36: 737–42
  • Wadee A, Paterson A., Coplan A. KA, Reddy S G. HLA expression in hepatocellular carcinoma cell lines. Clin Exp Immunol 1994; 97(2)328–33
  • Siavoshian Blottiere S., Bentouimou M. H, Cherbut N. C, Galmiche J P. Butyrate enhances major histocompatibility complex class, I. HLA-DR and ICAM-1 antigen expression on differentiated human intestinal epithelial cells. Eur J Clin Invest 1996; 26(9)803–10
  • Rocchi Ferreri P., Simone M. A, Granchi G., Paolucci D., Paolucci P. G. Growth inhibitory and differentiating effects of sodium butyrate on human neuroblastoma cells in culture. Anticancer Res 1992; 12(3)917–20
  • Madigan M, Chaudhri C., Penfold G. PL, Conway R M. Sodium butyrate modulates p53 and Bcl-2 expression in human retinoblastoma cell lines. Oncol Res 1999; 11(7)331–7
  • Krupitza Harant G., Dittrich H., Szekeres E., Huber T., Dittrich H. C. Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells. Carcinogenesis 1995; 16(5)1199–205
  • Takenaga K. Effect of butyric acid on lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells. Cancer Res 1986; 46(3)1244–9
  • Frankel Lew W., Su J., Bain B., Klurfeld A., Einhorn D., Mac E., Dermott R, Rombeau P. J. Butyrate increases colonocyte protein synthesis in ulcerative colitois. J Surg Res 1994; 57(1)210–4
  • Schroy P, Rustgi C., Konomu K. A, Liu E., Politop P. X, Andry J. C, Otceane J C. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. J Cell Physiol 1994; 161(1)111–23
  • Ohannessian D, Lotan W., Lotan D. R. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate. Cancer Res 1994; 54(22)5992–6000
  • Hardcastle J., Hardcastle P T. gamma-Aminobutyric acid and intestinal secretion. Gastroenterology 1996; 111(4)1163–4
  • Bartram H, Englert P., Scheppach S., Dusel W., Richter G., Richter F., Kasper A. H. Antagonist effects of deoxycholic acid and butyrate on epithelial cell proliferation in trait proximal and distal human colon. Z Gastroenterol 1994; 32(7)389–92
  • Velazquez O, Jabbar C., Dematteo A. RP, Rombeau J L. Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice. Surgery 1996; 120(2)440–7
  • Nuydens Heers R., Chadarevian C., de Jong A., Nuyens M., Cornelissen R., Geerts F. H. Sodium butyrate induces aberrant tau phosphorylation and programmed cell death in human neuroblastoma cells. Brain Res 1995; 688(1-2): 86–94
  • Conway R, Madigan M., Penfold C. MPL., Billson F A. Induction of apoptosis by sodium butyrate in the human Y-79 retinoblastoma cell line. Oncol Res 1995; 7(6)289–97
  • Coradini Biffi D., Costa A., Pellizzaro A., Pirronello C., Di E., Fronzo G. Effect of sodium butyrate on human breast cancer cell lines. Cell Prolif 1997; 30(3-4): 149–59
  • Thomas G, Henley L., Rowland A., Sahai C. T, Griffin A. M, Birckbichler P J. Enhanced apoptosis in transformed human lung fibroblasts after exposure to sodium butyrate. In vitro Cell Dev Biol Anim 1996; 32(8)505–13
  • Manual Wu M., Kumar X. R. Bcl-2 deregulation leads to inhibition of sodium butyrate-induced apoptosis in human colorectal carcinoma cells. Carcinogenesis 1997; 18(1)229–32
  • Carducci M, Nelson A., Chan B. J, Tack K, Ayyagari M., Sweatt R. S, Campbell H. W, Nelson A. PWG., Simons J W. Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin Cancer Res 1996; 2(2)379–87
  • Krurtta-Ochiai T. Fukushima, Ochiai K. K. Butyric acid-induced apoptosis of murine thymocytes, splenic T cells, and human Jurkat T cells. Infect Immun 1997; 65(1)35–41
  • Collins S, Ruscetti J., Gallagher W. FRE., Gallo R C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethylsulfoxide and other polar compounds. Proc Natl Acad Sci USA 1978; 75: 2458–2462
  • Garsetti Holtsberg D., Steiner F., Egan R. MRW., Clark M A. Butyric acid-induced differentiation of HL-60 cells increases the expression of a single lysophospholipase. Biochem J 1992; 288(Pt 3): 831–7
  • Atkins K B, Beitz D C. Effect of 1,10-phenanthroline on DNA binding by 1,25-(OH)2 vitamin D receptor. Horm Metab Res 1995; 27(10)455–60
  • Yen Varvayanis A. S. DMSO. sodium butyrate, and TPA induce hypophosphorylation of RB with HL-60 cells differentiation. In vitro Cell Dev Biol Anim 1995; 31(3)164–7
  • Rius Cabanas C., Aller C. P. The induction of vimentin gene expression by sodium butyrate in human promonocytic leukemia U937 cells. Exp Cell Res 1990; 188(1)129–34
  • Fraser J K, Berridge M V. Induction of B-lymphocyte antigens on the chronic myeloid leukemic cell line K562 using sodium butyrate. Exp Hematol 1987; 15(4)406–13
  • Breitman T R, He R Y. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL-60. Cancer Res 1990; 50(19)6268–73
  • Santini Scappini V., Gozzini B., Grossi A., Villa A., Ronco P., Douillet G., Pouillart O., Bernabei P., Rossi A. P, Ferrini P. Butyrate-stable monosaccharide derivatives induce maturation and apoptosis in human acute myeloid leukaemia cells. Br J Haematol 1998; 101: 529–538
  • Santini Gozzini V., Scappini A., Caporale B., Zoccolante R., Rigacci A., Gelardi L., Grossi E., Alterini A., Rossi R., Ferrini P. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells. Haematologica 1999; 84: 897–904
  • Gore S, Miller D., Weng B. C, Burks J. L, Griffin K., Chen A. C, Burke L. T, Grever J. PM., Rowinsky E K. Improved hematopoiesis in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) following administration of the putative differentiating agent sodium phenylbutyrate (SPB). Blood 1996; 88: 2315
  • Warrell R, He P., Richon Z. L, Calleja V. E, Pandolfi P P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 90(21) Nov 1998; 4: 1621–1625
  • Perrine R, Brown P., Clegg J. M, Weatherall B. J, May J. DA. Benign sickle-cell anaemia. Lancet 1972; 2: 1163
  • Stamatoyannopoulos G., Nienhuis A W. Hemoglobin switching. The molecular Basis of Blood Diseases, G. Stamatoyannopoulos, A W. Nienhuis, P. Leder, P Majerus. Saunders, Philadelphia, PA 1987; 66
  • Wood W, Felsenfeld I. G. Chromatin structure of the chicken beta-globin gene region. J Biol Chem 1982; 257: 7730
  • Perrine S, Miller P., Faller A. B, Cohen V. D, Vichinsky A. R, Hurst P. E, Lubin D., Papayannopoulo H. BTh. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with HbSS and beta thalassemia. Blood 1989; 74: 454
  • Desimone Heller J., Hall P., Zwiers D. 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci USA 1982; 79: 44–28
  • Rodgers G, Dover P., Noguchi J. G, Schechter T. CAN., Nienhuis A W. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Me 1990; 12322(15)1037–45
  • Veith Galanello R., Papayannopoulou R. Th, Stamatoyannopoulos G. Stimulation of F-cell production in patients with sickle-cell anaemia treated with cytarabine or hydroxyurea. N Engl J Med 1986; 313: 1571
  • Constantoulakis Knitter P., Stamatoyannopoulos G. G. On the induction of fetal hemoglobin by buryrates: In vivo and In vitro studies with sodium butyrate and comparison of combination therapy with S-Aza C and Ara-C. Blood 1989; 74: 1963
  • Blau Constantoulakis A., Shaw P., Stamatoyannopoulos M. CG. Fetal hemoglobin induction with butyric acid: efficacy and toxicity. Blood 1993; 81(2)529–537
  • Perrine S, Ginder P., Faller D. G, Dover V. D, Ikuta J. G, Witkowska T., Cai E. HS-P, Vichinsky E P, Olivieri N F. A short term trial of butyrate to stimulate fetal-globin gene expression in the beta-globin disorders. Engl J Med 1993; 328: 81
  • Sher G, Entsuah D., Ginder B., Dover G., Ittle G., Donsky J., Berkovitch J., Lewis M., Chang N., Perrine L. S, Olivieri N F. Intravenous infusion of arginine butyrate increases gamma globin mRNA expression and F-reticulocytes in patients with homozygous beta-thalassemia and sickle cell disease. Blood 1993; 82: 312a, (suppl Abstr)
  • Collins A, Luban F. NLC, Dover G J. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy. Blood 1994; 84: 1690, (Letter)
  • Dover G, Brusilow J., Charache W. SS. Induction of HbF production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 1994; 84: 339
  • Collins A, Pearsn F., Giardina A. H, Mc P., Donagh T, Brusilow K. SW, Dover G J. Oral sodium phenylbutyrate therapy in homozigous beta-thalassemia: a clinical trial. Blood 1995; 85(1)43–49
  • Stamatoyannopoulos Blau G., Nakamoto A. C, Josephson B., Li B., Liakopoulou Q., Pace E., Papayannopoulou B. Th, Brusilow S, Dover W. G. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood 1994; 84(9)3198–204
  • Atweh G, Sutton F., Nassif M., Boosalis I., Dover V., Wallenstein J. G, Wright S., Mm Mahon E., Stamatoyannopoulos L., Faller G. DV, Perrine S P. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 1999; 93(6)1790–7
  • Steinberg M, Lu H., Barton H. Z, Terrin B. F, Charache L. MS., Dover G J. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 1997; 89(3)1078–88

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.